Anavex Life Sciences's total assets for Q1 2026 were $132.99M, an increase of 28.10% from the previous quarter. AVXL total liabilities were $6.37M for the fiscal quarter, a -28.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.